CapsoVision (CV) said late Tuesday it priced its initial public offering of 5.5 million shares at $5 per share, targeting gross proceeds of about $27.5 million.
The medical technology company said the shares are expected to begin trading on Nasdaq under the ticker "CV" from Wednesday.
The offering is expected to close on Thursday.
CapsoVision said it granted the underwriters a 30-day option to purchase up to an additional 825,000 shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.